Fibromyalgia & Genetics: What New Research Is Telling Us About Chronic Pain
Fibromyalgia has long been understood as a complex condition involving the nervous system, pain processing, and a variety of biological and environmental factors. But what role does genetics play?
New research is beginning to provide some fascinating answers.
A recent genetic study identified 26 new genetic loci associated with fibromyalgia, providing additional evidence that genetics may play an important role in understanding why some people develop fibromyalgia and chronic widespread pain.
One of the Most Interesting Findings: Huntington’s Disease
One of the most notable findings from the study was a strong genetic association between fibromyalgia and a gene associated with Huntington’s disease.
This does not mean that having fibromyalgia means you have Huntington’s disease—or that someone with fibromyalgia is going to develop it.
Instead, researchers are interested in the biological pathways that these conditions may share. Identifying genetic connections can help researchers better understand the mechanisms involved in pain processing and potentially identify new targets for treatment.
26 New Genetic Loci Identified
Researchers also identified 26 previously unreported genetic loci associated with fibromyalgia.
A genetic locus is a specific location on a chromosome that can contain genetic variants associated with a particular trait or condition.
These findings are important because fibromyalgia is not caused by a single gene. It appears to be influenced by many genetic variations, along with other biological and environmental factors.
Understanding these genetic associations may eventually help researchers identify different biological subtypes of fibromyalgia and develop more targeted treatments.
What About Musculoskeletal Pain?
Another interesting finding was the strong association between fibromyalgia and comorbid musculoskeletal dysfunction and pain.
This is particularly relevant from a physical therapy perspective.
People with fibromyalgia frequently experience widespread musculoskeletal pain, fatigue, reduced physical capacity, and changes in how the body processes and responds to sensory input.
While genetics do not explain everything about fibromyalgia, these findings may help us better understand why musculoskeletal pain and dysfunction are so closely intertwined with the condition.
What Does This Mean for Treatment?
Perhaps one of the most exciting implications of this research is the potential for drug repurposing.
Drug repurposing involves investigating medications that are already approved for other conditions to determine whether they could be useful for treating another condition.
If researchers can identify specific genetic pathways involved in fibromyalgia, they may be able to determine whether existing medications that target those pathways could also help people with fibromyalgia.
This could potentially speed up the development of new treatment options because the safety profiles of existing medications are already better understood.
There Is Still More Research to Do
One important limitation of this study is the genetic makeup of the participants.
The study population consisted primarily of individuals of European ancestry, meaning these findings may not fully represent the genetic factors involved in fibromyalgia across different populations.
Future research will need to include people from much wider and more diverse genetic backgrounds to determine whether these associations are consistent across populations.
The Future of Fibromyalgia Research
Fibromyalgia is increasingly being recognized as a complex, multifactorial condition rather than simply a diagnosis of unexplained pain.
Genetic research may help us better understand why certain individuals develop fibromyalgia, why symptoms can vary so dramatically between people, and which biological pathways could be targeted with future treatments.
There is still a lot we don’t know—but identifying new genetic associations is an important step toward understanding the biology behind fibromyalgia.
And ultimately, better understanding the biology may lead to more personalized and effective treatments for people living with chronic pain.
This research is still emerging, and genetic associations do not establish that a particular gene causes fibromyalgia. More research is needed to determine how these findings can be translated into clinical treatment.
References: https://pmc.ncbi.nlm.nih.gov/articles/PMC13472937/